One drop of blood is all it takes
to test for any biomarker at home
DEMOCRATIZING
CLINICAL DATA
INVESTORS
About
The company has a product for blood biomarker testing. Customers demand this type of product and several contacts have already been made with vital institutions in Denmark. Sales for professional use are commenced in 2020.
Investors
Here you will find the share information for Qlife Holding AB. Our press releases and financial quarterly reports, our annual reports, calendar and information about our corporate governance work. Qlife Holding AB aims for a fast and transparent accounting to shareholders and the financial market.
The company is listed on Nasdaq, First North Growth Market, Stockholm as from March 2, 2020
Egoo.health
The Egoo product is a platform for accurate bio-marker testing. At a low cost and with equipment easy to use, it measures and analyses the patient’s blood. The patient can do the testing at home themselves. Read more on our product page.
Contact
If you have any questions about us or our ongoing IPO feel free to send us a message.
In less than four minutes, CEO Thomas Warthoe explains what Egoo Health is all about, how it works and why it makes a difference for ordinary people, medical staff and health institutions.